The paradigm shift is radical. From an extremely bleak prognosis just a few years ago, lung cancer has moved into an intermediate state, opening the door to many possibilities. “The patient with metastasized lung cancer is no longer told: “We can’t heal you”shows Pr: Benjamin Bess, Director of Clinical Research at Gustave-Roussi. “Terms”chronic disease” or ‘disease control’ seems more appropriate to me because some treatments can work very well and for a long time.”
Let’s face it, lung cancer is both one of the most common in France (46,000 new cases per year according to Inca 2018), the deadliest in men, and the second most common in women (over 30,000 deaths in 2018). “But in between there are people who live with the disease.” recalls Laure Guéroult Accolas, founder of Patients in Network. “Some patients with stage 4 cancer (most serious, editor’s note) can through immunotherapy…
Source: Le Figaro
